Digital Health Startups

Velocity operates dedicated and embedded clinical research sites across the United States, providing the staff, equipment, study contracting, regulatory documentation, and business development support needed to run clinical trials. It partners with physician groups, independent practices, and health centers to add research capabilities and covers a wide range of therapeutic areas.

2 investors

Veri provides personalized metabolic health monitoring and guidance using science-based technology to help individuals understand their body's unique needs and improve their health outcomes. The company serves consumers seeking to address metabolic health issues through daily nutritional and lifestyle insights.

2 investors

GENFIT is a biopharmaceutical company developing therapies for rare, life-threatening liver diseases, with a focus on acute-on-chronic liver failure (ACLF), hepatic encephalopathy (HE), cholangiocarcinoma, urea cycle disorders, and organic acidemias. Its pipeline spans eight R&D programs plus a diagnostic franchise for NASH/MASH and ammonia, and it discovered elafibranor, now approved and marketed as Iqirvo for primary biliary cholangitis.

2 investors

Verse Therapy provides a practice management platform that helps independent speech-language pathologists handle administrative work, insurance processing, scheduling, and documentation while connecting them with clients through partnerships and marketing support. The service aims to reduce administrative burden on therapists so they can focus on patient care.

2 investors

VeVe is a mobile-first digital collectibles and comics platform where users can buy, sell, and trade licensed 3D collectibles, artworks, and interactive digital comics from major entertainment brands. The platform serves collectors globally through an NFT marketplace with augmented reality features and integrates blockchain technology with a focus on carbon-neutral operations.

2 investors

Vheda Health offers turnkey, evidence-based chronic care, behavioral health, and maternal health programs delivered virtually to Medicaid, Medicare, and SNP health plans across the US. Its programs aim to increase member engagement, lower costs through reduced ER utilization and admissions, and improve health and quality outcomes.

2 investors

Vial develops first- and best-in-class biologics — including RNA, antibody, and small molecule programs — using AI-driven target discovery, molecule design, and high-throughput experimental validation, focused on immunology and inflammatory disorders. It also runs programs through its own clinical trial platform for automated clinical trials.

2 investors

Via Nova develops antiviral therapies targeting acute and subacute viral infections, including respiratory, gastrointestinal, and neurological infections. The company focuses on infections with high prevalence and severe illness potential, serving patients with unmet treatment needs across multiple viral categories.

2 investors

Vibrant Gastro develops a drug-free medical device using micro-vibrations to treat chronic idiopathic constipation in adults. The company's Vibrant System employs the Synchronized Activation Method to mechanically stimulate the colon and improve natural bowel motility.

2 investors

Vigilant Biosciences develops diagnostic technology for early detection of oral cancer, with products aimed at dental practices and clinicians. Its lead system has received FDA Breakthrough Device Designation.

2 investors

VillageMD is a primary care platform providing high-quality community-based healthcare services across the United States, focusing on preventive care and chronic disease management. The company operates Village Medical practices, some co-located with Walgreens pharmacies, and offers virtual and home-based care services.

2 investors

Kindbridge is a telehealth platform that delivers behavioral health services for individuals struggling with gambling-related harm, digital dependencies, and mental health challenges. The company combines clinical expertise with technology to provide therapy, counseling, and educational programs through licensed clinicians.

2 investors

Virtuleap develops VR and AI-based cognitive therapeutics and diagnostics, including cognitive training tools used in research and clinical settings for conditions such as cognitive decline, anxiety, and addiction. Its products are used by healthcare researchers and clinicians studying executive function, mental wellness, and rehabilitation.

2 investors

Visionable enables direct connections between hospitals and patients and facilitates collaboration among healthcare teams across multiple locations. The company provides connectivity solutions designed to improve clinical care accessibility and equity within healthcare systems.

2 investors

Vita Health provides virtual mental health care for adults and children through a network of vetted providers who deliver personalized treatment plans based on clinical data and evidence-based practices. The service offers convenient online appointments with dedicated care coordination.

2 investors

Vitagene offers an at-home sleep test that measures biomarkers such as cortisol and melatonin to help individuals identify the causes of their sleep problems and stress. The product is a direct-to-consumer diagnostic aimed at people seeking to understand their sleep and stress patterns.

2 investors

VitalConnect develops wearable biosensor technology for remote and in-hospital patient monitoring, streaming up to 11 vital signs including live ECG to enable physicians to monitor patients recovering at home or in the hospital. Its cardiac monitoring solution serves healthcare providers and is used for applications such as extended Holter cardiac monitoring and COVID-19 patient care.

2 investors

Vital provides an AI-driven patient experience product for hospital emergency departments that uses real-time EHR data to predict wait times, explain lab results and notes in plain language, and turn discharge instructions into a checklist accessed via a password-less text link. It sells to hospitals and EDs, integrating on top of major EHR systems through FHIR or HL7 to reduce LWOBS/AMA rates and improve patient satisfaction scores.

2 investors

Vitalliance is a French home-care provider offering in-home assistance for elderly people and people with disabilities, including support for conditions such as Alzheimer's, Parkinson's, multiple sclerosis, and autism. It provides live-in and hourly caregivers, inclusive housing, and telecare services across France through a network of local agencies.

2 investors

VitalSigns develops a smart diagnostic device that captures and analyzes multiple bio-signals simultaneously for primary care, home monitoring, and telemedicine applications. The company combines hardware and AI to support clinical decision-making in primary care and nursing settings across Europe.

2 investors

VitalTech develops solutions for virtual care delivery that optimize performance across the healthcare continuum for clients and their patients. The company forms strategic partnerships to transform healthcare delivery through digital technology.

2 investors

Vitract develops an advanced gut testing platform using whole-genome sequencing and AI analytics to assess microbiome health and provide personalized insights. The company serves individuals seeking diagnostic and preventive gut health solutions grounded in microbiome science.

2 investors

Vitro is a clinician-designed digital medical record system that digitises hospitals' existing paper forms, pathways and workflows, capturing clinical data at the bedside and integrating scanned historical records with lab, radiology and patient administration results. It serves healthcare providers such as acute hospitals, hospices, mental health services and screening programmes across multiple continents.

2 investors

AWAK Technologies develops a wearable peritoneal dialysis device that enables patients with end-stage renal disease to receive treatment at home or on the move, using regeneration technology that reduces dialysis fluid consumption by up to 90 percent. The company serves kidney disease patients seeking greater mobility and quality of life compared to traditional stationary dialysis machines.

2 investors